By Özge ÖzkayaClinical Trial Tested Safety of Potential New Drug to Manage Endometriosis
By Özge Özkaya
The non-peptide gonadotropin-releasing hormone antagonist SHR7280 has favorable safety, pharmacokinetics, and pharmacodynamics in 3 different doses, according to the results of a phase 1 clinical trial published in the scientific journal Clinical Pharmacokinetics. “The results of this study provide evidence to…
Key Points Lay Summary
Women With Endo Left Alone To Deal With Their Gut Symptoms
By Özge Özkaya
Women with endometriosis had patterns of restrictive behavior, according to a new study published in the European Journal of Obstetrics & Gynecology and Reproductive Biology. They also wanted more professional support to help them manage the gut symptoms associated with the…
Key Points Lay Summary
Dietary adjustments do not increase the quality of life of women with endometriosis.
By Özge Özkaya
Even though dietary changes do not seem to increase patients’ quality of life, they lead to a perceived reduction in symptoms. No specific adjustment in the diet increases the quality of life of women with endometriosis, according to a new…
Key Points Lay Summary